Jump to main content
Jump to site search

Issue 6, 2013
Previous Article Next Article

The impact of mass spectrometry on the study of intact antibodies: from post-translational modifications to structural analysis

Author affiliations

Abstract

Monoclonal antibodies (mAbs) are important therapeutics, targeting a variety of diseases ranging from cancers to neurodegenerative disorders. In developmental stages and prior to clinical use, these molecules require thorough structural characterisation, but their large size and heterogeneity present challenges for most analytical techniques. Over the past 20 years, mass spectrometry (MS) has transformed from a tool for small molecule analysis to a technique that can be used to study large intact proteins and non-covalent protein complexes. Here, we review several MS-based techniques that have emerged for the analysis of intact mAbs and discuss the prospects of using these technologies for the analysis of biopharmaceuticals.

Graphical abstract: The impact of mass spectrometry on the study of intact antibodies: from post-translational modifications to structural analysis

Back to tab navigation

Article information


Submitted
17 Sep 2012
Accepted
14 Nov 2012
First published
15 Nov 2012

Chem. Commun., 2013,49, 538-548
Article type
Feature Article

The impact of mass spectrometry on the study of intact antibodies: from post-translational modifications to structural analysis

N. J. Thompson, S. Rosati, R. J. Rose and A. J. R. Heck, Chem. Commun., 2013, 49, 538
DOI: 10.1039/C2CC36755F

Social activity

Search articles by author

Spotlight

Advertisements